To print: Select File and then Print from your browser's menu
---------------------------------------------------------------------------------------
Title: FDA Approves Quetiapine Fumarate for the Treatment of Bipolar Depression, Mania
URL: http://www.pslgroup.com/dg/22E7EE.htm
Doctor's Guide
October 10, 2008

NEW YORK -- October 10, 2008 -- The US Food and Drug Administration (FDA) has approved once-daily quetiapine fumarate (Seroquel XR) extended-release tablets for the acute treatment of the depressive episodes associated with bipolar disorder, the manic and mixed episodes associated with bipolar I disorder, and the maintenance treatment of bipolar I disorder as adjunctive therapy to lithium or divalproex.

"When people think about bipolar disorder it is important to remember how debilitating the depressive episodes of the disease can be. In fact, in the long term, patients with bipolar disorder experience depressive symptoms 3 times longer than manic symptoms," said Trisha Suppes, MD, Stanford University Medical Center, Stanford, California, and VA Palo Alto Health Care System, Palo Alto, California.

"With the approval of [extended release quetiapine fumarate] for the treatment of bipolar depression and mania, we have a once-daily treatment that has been proven to help control the depressive and manic symptoms of bipolar disorder."


SOURCE: AstraZeneca

---------------------------------------------------------------------------------------------
Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.
---------------------------------------------------------------------------------------------
This news story was printed from *Doctor's Guide to the Internet*
located at http://www.docguide.com
---------------------------------------------------------------------------------------

Return to News Story Page

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.
All contents Copyright (c) 1998 P\S\L Consulting Group Inc.
All rights reserved.